Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing

PURPOSE: Current chemotherapy fails to offer a desirable efficacy in clinical treatment against breast cancer due to the extensive multi-drug resistance. In this study, we developed dual sensitization anti-resistant nanoparticles to treat refractory breast cancer, aiming to benefit from photodynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Ruijun, Wu, Faliang, Tian, Yanzhao, Chu, Jiahao, Peng, Xiaoming, Wang, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926987/
https://www.ncbi.nlm.nih.gov/pubmed/36798807
http://dx.doi.org/10.2147/DDDT.S387788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926987/
https://www.ncbi.nlm.nih.gov/pubmed/36798807
http://dx.doi.org/10.2147/DDDT.S387788

Ejemplares similares